Founded in 2016, Hongkong Huangdaoyi Medicine Group Holdings, classified under reg no. 09977826 is an active company. Currently registered at Suite 108 Chase Business Centre N14 5BP, London the company has been in the business for eight years. Its financial year was closed on Wednesday 31st January and its latest financial statement was filed on 31st January 2023.
The firm has one director. Yongquan P., appointed on 17 August 2016. There are currently no secretaries appointed. As of 15 May 2024, there was 1 ex director - Weijie P.. There were no ex secretaries.
Office Address | Suite 108 Chase Business Centre |
Office Address2 | 39-41 Chase Side |
Town | London |
Post code | N14 5BP |
Country of origin | United Kingdom |
Registration Number | 09977826 |
Date of Incorporation | Fri, 29th Jan 2016 |
Industry | Dormant Company |
End of financial Year | 31st January |
Company age | 8 years old |
Account next due date | Thu, 31st Oct 2024 (169 days left) |
Account last made up date | Tue, 31st Jan 2023 |
Next confirmation statement due date | Thu, 15th Feb 2024 (2024-02-15) |
Last confirmation statement dated | Wed, 1st Feb 2023 |
The register of persons with significant control who own or have control over the company is made up of 3 names. As we identified, there is Yuanzong C. The abovementioned PSC and has 75,01-100% shares. The second entity in the persons with significant control register is Weijie P. This PSC owns 75,01-100% shares and has 75,01-100% voting rights. Moving on, there is Yongquan P., who also fulfils the Companies House conditions to be listed as a PSC. This PSC has significiant influence or control over the company, owns 75,01-100% shares and has 75,01-100% voting rights.
Yuanzong C.
Notified on | 6 June 2022 |
Nature of control: |
75,01-100% shares |
Weijie P.
Notified on | 14 March 2018 |
Ceased on | 6 June 2022 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Yongquan P.
Notified on | 17 August 2016 |
Ceased on | 14 March 2018 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors significiant influence or control |
Profit & Loss | ||||||||
---|---|---|---|---|---|---|---|---|
Accounts Information Date | 2017-01-31 | 2018-01-31 | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 |
Net Worth | 500 000 | 500 000 | ||||||
Balance Sheet | ||||||||
Net Assets Liabilities | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 | |
Net Assets Liabilities Including Pension Asset Liability | 500 000 | 500 000 | ||||||
Reserves/Capital | ||||||||
Shareholder Funds | 500 000 | 500 000 | ||||||
Other | ||||||||
Called Up Share Capital Not Paid Not Expressed As Current Asset | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 |
Number Shares Allotted | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 | 500 000 |
Par Value Share | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Share Capital Allotted Called Up Paid | 500 000 | 500 000 |
Type | Category | Free download | |
---|---|---|---|
CS01 |
Confirmation statement with no updates 17th January 2024 filed on: 17th, January 2024 |
confirmation statement | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy